STOCK TITAN

Femasys (NASDAQ: FEMY) CFO receives 342,000 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Femasys Inc. Chief Financial Officer Dov Elefant reported awards of restricted stock units (RSUs) that give him the right to acquire FEMY common shares in the future. He received 173,000 RSUs and 169,000 RSUs, each representing one share when vested. One grant vests in four equal annual installments beginning on February 19, 2027, while the other fully vests on February 19, 2027, in each case contingent on continued employment with the company or a subsidiary on the applicable vesting dates.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Elefant Dov

(Last) (First) (Middle)
C/O FEMASYS INC.
3950 JOHNS CREEK COURT, SUITE 100

(Street)
SUWANEE GA 30024

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 02/19/2026 A 173,000 (2) (2) Common Stock 173,000 $0 173,000 D
Restricted Stock Units (1) 02/19/2026 A 169,000 (3) (3) Common Stock 169,000 $0 169,000 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of FEMY common stock.
2. The restricted stock units vest in 4 equal annual installments beginning February 19, 2027, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
3. The restricted stock units fully vest on February 19, 2027, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
/s/ Kathy Lee-Sepsick, Attorney-in-fact 02/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did FEMASYS INC (FEMY) report for Dov Elefant?

Femasys reported that Chief Financial Officer Dov Elefant received two grants of restricted stock units. The awards cover 173,000 RSUs and 169,000 RSUs, each convertible into one share of FEMY common stock upon vesting, subject to his continued employment.

How many restricted stock units did FEMY’s CFO receive in this Form 4?

The CFO received two RSU awards totaling 342,000 units, split into grants of 173,000 and 169,000 RSUs. Each restricted stock unit represents a contingent right to receive one share of FEMASYS INC common stock, assuming all vesting conditions are satisfied.

When do Dov Elefant’s FEMASYS (FEMY) RSU awards vest?

One RSU grant vests in four equal annual installments beginning February 19, 2027. The second grant fully vests on February 19, 2027. Both vesting schedules require that Dov Elefant remain employed by Femasys or a subsidiary on the relevant vesting dates.

What are the key conditions attached to FEMY’s RSU grants to its CFO?

Each restricted stock unit converts into one FEMY share only if vesting conditions are met. Vesting requires that the reporting person, CFO Dov Elefant, remain employed by FEMASYS INC or a subsidiary on the applicable vesting dates specified for each RSU award.

Did FEMASYS INC’s CFO buy or sell shares in this Form 4 filing?

The Form 4 reflects acquisitions of equity awards rather than market purchases or sales. Dov Elefant received RSUs as grants with a zero dollar price per unit, representing future rights to FEMY shares if vesting and employment conditions are satisfied.
FEMASYS INC

NASDAQ:FEMY

FEMY Rankings

FEMY Latest News

FEMY Latest SEC Filings

FEMY Stock Data

32.49M
53.56M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE